0
USD
U.S. (TOLL FREE)
+1 (315) 215-3225
Automative

0
U.S. (TOLL FREE)
+1 (315) 215-3225
Global Gene Editing Market Size, Status and Forecast 2019-2025
Published Date: April 2019
|
Report Code: QYRE-Othe-091
Home | Market Reports |Science |Biological Sciences
Global Gene Editing Market Size Status and Forecast 2019 to 2025

Global Gene Editing Market Size, Status and Forecast 2019-2025

Code: QYRE-Othe-091
Report
April 2019
102 Pages
QYResearch
Region: Global,
Description
Table of Content
Tables & Figures

Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
Based on end user, the global gene editing technologies market has been segmented into biotechnology industry, horticulture industry, animal breeding and academic & research institutes. Academic and research institutes are expected to contribute maximum share in the global gene editing technologies market over the f recast period as majority of the therapeutic applications of gene editing are not yet commercialized.
United States is expected to lead the global market due to increasing number academic and research institutes. Market in APAC region is expected to witness significant growth rate over the forecast period owing to expansion activities by key market players in the region.
In 2018, the global Gene Editing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gene Editing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Editing development in United States, Europe and China.

The key players covered in this study
Thermo Fisher Scientific
Merck
Horizo​​n Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
OriGene Technologies
Agilent Technologies

Market analysis by product type
Crispr
Talen
Zfn

Market analysis by market
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations

Market analysis by Region
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gene Editing status, future forecast, growth opportunity, key market and key players.
To present the Gene Editing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gene Editing are as follows:
History Year: 2018-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type

1.4.2 Crispr
1.4.3 Talen
1.4.4 Zfn
1.5 Market by Application
1.5.1 Global Gene Editing Market Share by Application (2018-2025)
1.5.2 Biotechnology & Pharmaceutical Companies
1.5.3 Academic & Government Research Institutes
1.5.4 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Gene Editing Market Size
2.2 Gene Editing Growth Trends by Regions
2.2.1 Gene Editing Market Size by Regions (2018-2025)
2.2.2 Gene Editing Market Share by Regions (2018-2025)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Gene Editing Revenue by Manufacturers (2018-2019)
3.2 Gene Editing Key Players Head office and Area Served
3.3 Key Players Gene Editing Product/Solution/Service
3.4 Date of Enter into Gene Editing Market
3.5 Key Players Gene Editing Funding/Investment Analysis
3.6 Global Key Players Gene Editing Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Editing Market Size by Type (2018-2025)
4.2 Global Gene Editing Market Size by Application (2017-2025)

5 United States
5.1 United States Gene Editing Market Size (2018-2025)
5.2 Gene Editing Key Players in United States
5.3 United States Gene Editing Market Size by Type
5.4 United States Gene Editing Market Size by Application

6 Europe
6.1 Europe Gene Editing Market Size (2018-2025)
6.2 Gene Editing Key Players in Europe
6.3 Europe Gene Editing Market Size by Type
6.4 Europe Gene Editing Market Size by Application

7 China
7.1 China Gene Editing Market Size (2018-2025)
7.2 Gene Editing Key Players in China
7.3 China Gene Editing Market Size by Type
7.4 China Gene Editing Market Size by Application

8 Rest of World
8.1 Japan
8.1.1 Japan Gene Editing Market Analysis
8.1.2 Key Players in
8.2 Southeast Asia
8.2.1 Southeast Asia Gene Editing Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Gene Editing Market Analysis
8.3.2 Key Players in India

9 International Players Profiles
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Company Details
9.1.2 Company Description and Business Overview
9.1.3 Gene Editing Introduction
9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2018-2019)
9.1.5 Thermo Fisher Scientific Recent Development
9.2 Merck
9.2.1 Merck Company Details
9.2.2 Company Description and Business Overview
9.2.3 Gene Editing Introduction
9.2.4 Merck Revenue in Gene Editing Business (2018-2019)
9.2.5 Merck Recent Development
9.3 Horizo​​n Discovery
9.3.1 Horizo​​n Discovery Company Details
9.3.2 Company Description and Business Overview
9.3.3 Gene Editing Introduction
9.3.4 Horizo​​n Discovery Revenue in Gene Editing Business (2018-2019)
9.3.5 Horizo​​n Discovery Recent Development
9.4 Sangamo BioSciences
9.4.1 Sangamo BioSciences Company Details
9.4.2 Company Description and Business Overview
9.4.3 Gene Editing Introduction
9.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2018-2019)
9.4.5 Sangamo BioSciences Recent Development
9.5 Integrated DNA Technologies
9.5.1 Integrated DNA Technologies Company Details
9.5.2 Company Description and Business Overview
9.5.3 Gene Editing Introduction
9.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2017-2018)
9.5.5 Integrated DNA Technologies Recent Development
9.6 Lonza
9.6.1 Lonza Company Details
9.6.2 Company Description and Business Overview
9.6.3 Gene Editing Introduction
9.6.4 Lonza Revenue in Gene Editing Business (2017-2018)
9.6.5 Lonza Recent Development
9.7 New England Biolabs
9.7.1 New England Biolabs Company Details
9.7.2 Company Description and Business Overview
9.7.3 Gene Editing Introduction
9.7.4 New England Biolabs Revenue in Gene Editing Business (2018-2019)
9.7.5 New England Biolabs Recent Development
9.8 OriGene Technologies
9.8.1 OriGene Technologies Company Details
9.8.2 Company Description and Business Overview
9.8.3 Gene Editing Introduction
9.8.4 OriGene Technologies Revenue in Gene Editing Business (2018-2019)
9.8.5 OriGene Technologies Recent Development
9.9 Transposagen Biopharmaceuticals
9.9.1 Transposagen Biopharmaceuticals Company Details
9.9.2 Company Description and Business Overview
9.9.3 Gene Editing Introduction
9.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2018-2019)
9.9.5 Transposagen Biopharmaceuticals Recent Development
9.10 Editas Medicine
9.10.1 Editas Medicine Company Details
9.10.2 Company Description and Business Overview
9.10.3 Gene Editing Introduction
9.10.4 Editas Medicine Revenue in Gene Editing Business (2018-2019)
9.10.5 Editas Medicine Recent Development
9.11 CRISPR Therapeutics
9.12 RGen Solutions
9.13 Sigma-Aldrich
9.14 GeneCopoeia
9.15 Genscript Biotech
9.16 OriGene Technologies
9.17 Agilent Technologies

10 Market Dynamics
10.1 Drivers
10.2 Opportunities
10.3 Challenges
10.4 Market Ecosystem
10.5 Market Value Chain Analysis

11 Key Findings in This Report

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details


1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type

1.4.2 Crispr
1.4.3 Talen
1.4.4 Zfn
1.5 Market by Application
1.5.1 Global Gene Editing Market Share by Application (2018-2025)
1.5.2 Biotechnology & Pharmaceutical Companies
1.5.3 Academic & Government Research Institutes
1.5.4 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Gene Editing Market Size
2.2 Gene Editing Growth Trends by Regions
2.2.1 Gene Editing Market Size by Regions (2018-2025)
2.2.2 Gene Editing Market Share by Regions (2018-2025)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Gene Editing Revenue by Manufacturers (2018-2019)
3.2 Gene Editing Key Players Head office and Area Served
3.3 Key Players Gene Editing Product/Solution/Service
3.4 Date of Enter into Gene Editing Market
3.5 Key Players Gene Editing Funding/Investment Analysis
3.6 Global Key Players Gene Editing Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Editing Market Size by Type (2018-2025)
4.2 Global Gene Editing Market Size by Application (2017-2025)

5 United States
5.1 United States Gene Editing Market Size (2018-2025)
5.2 Gene Editing Key Players in United States
5.3 United States Gene Editing Market Size by Type
5.4 United States Gene Editing Market Size by Application

6 Europe
6.1 Europe Gene Editing Market Size (2018-2025)
6.2 Gene Editing Key Players in Europe
6.3 Europe Gene Editing Market Size by Type
6.4 Europe Gene Editing Market Size by Application

7 China
7.1 China Gene Editing Market Size (2018-2025)
7.2 Gene Editing Key Players in China
7.3 China Gene Editing Market Size by Type
7.4 China Gene Editing Market Size by Application

8 Rest of World
8.1 Japan
8.1.1 Japan Gene Editing Market Analysis
8.1.2 Key Players in
8.2 Southeast Asia
8.2.1 Southeast Asia Gene Editing Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Gene Editing Market Analysis
8.3.2 Key Players in India

9 International Players Profiles
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Company Details
9.1.2 Company Description and Business Overview
9.1.3 Gene Editing Introduction
9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2018-2019)
9.1.5 Thermo Fisher Scientific Recent Development
9.2 Merck
9.2.1 Merck Company Details
9.2.2 Company Description and Business Overview
9.2.3 Gene Editing Introduction
9.2.4 Merck Revenue in Gene Editing Business (2018-2019)
9.2.5 Merck Recent Development
9.3 Horizo​​n Discovery
9.3.1 Horizo​​n Discovery Company Details
9.3.2 Company Description and Business Overview
9.3.3 Gene Editing Introduction
9.3.4 Horizo​​n Discovery Revenue in Gene Editing Business (2018-2019)
9.3.5 Horizo​​n Discovery Recent Development
9.4 Sangamo BioSciences
9.4.1 Sangamo BioSciences Company Details
9.4.2 Company Description and Business Overview
9.4.3 Gene Editing Introduction
9.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2018-2019)
9.4.5 Sangamo BioSciences Recent Development
9.5 Integrated DNA Technologies
9.5.1 Integrated DNA Technologies Company Details
9.5.2 Company Description and Business Overview
9.5.3 Gene Editing Introduction
9.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2017-2018)
9.5.5 Integrated DNA Technologies Recent Development
9.6 Lonza
9.6.1 Lonza Company Details
9.6.2 Company Description and Business Overview
9.6.3 Gene Editing Introduction
9.6.4 Lonza Revenue in Gene Editing Business (2017-2018)
9.6.5 Lonza Recent Development
9.7 New England Biolabs
9.7.1 New England Biolabs Company Details
9.7.2 Company Description and Business Overview
9.7.3 Gene Editing Introduction
9.7.4 New England Biolabs Revenue in Gene Editing Business (2018-2019)
9.7.5 New England Biolabs Recent Development
9.8 OriGene Technologies
9.8.1 OriGene Technologies Company Details
9.8.2 Company Description and Business Overview
9.8.3 Gene Editing Introduction
9.8.4 OriGene Technologies Revenue in Gene Editing Business (2018-2019)
9.8.5 OriGene Technologies Recent Development
9.9 Transposagen Biopharmaceuticals
9.9.1 Transposagen Biopharmaceuticals Company Details
9.9.2 Company Description and Business Overview
9.9.3 Gene Editing Introduction
9.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2018-2019)
9.9.5 Transposagen Biopharmaceuticals Recent Development
9.10 Editas Medicine
9.10.1 Editas Medicine Company Details
9.10.2 Company Description and Business Overview
9.10.3 Gene Editing Introduction
9.10.4 Editas Medicine Revenue in Gene Editing Business (2018-2019)
9.10.5 Editas Medicine Recent Development
9.11 CRISPR Therapeutics
9.12 RGen Solutions
9.13 Sigma-Aldrich
9.14 GeneCopoeia
9.15 Genscript Biotech
9.16 OriGene Technologies
9.17 Agilent Technologies

10 Market Dynamics
10.1 Drivers
10.2 Opportunities
10.3 Challenges
10.4 Market Ecosystem
10.5 Market Value Chain Analysis

11 Key Findings in This Report

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details

List of Tables and Figures

Table Gene Editing Key Market Segments
Table Key Players Gene Editing Covered
Table Global Gene Editing Market Size Growth Rate by Type 2019-2025 (Million US$)
Figure Global Gene Editing Market Size Market Share by Type 2019-2025
Figure Crispr Figures
Table Key Players of Crispr
Figure Talen Figures
Table Key Players of Talen
Figure Zfn Figures
Table Key Players of Zfn
Table Global Gene Editing Market Size Growth by Application 2019-2025 (Million US$)
Figure Biotechnology & Pharmaceutical Companies Case Studies
Figure Academic & Government Research Institutes Case Studies
Figure Contract Research Organizations Case Studies
Figure Gene Editing Report Years Considered
Table Global Gene Editing Market Size 2018-2025 (Million US$)
Figure Global Gene Editing Market Size and Growth Rate 2018-2025 (Million US$)
Table Global Gene Editing Market Size by Regions 2019-2025 (Million US$)
Table Global Gene Editing Market Size by Regions 2018-2025 (Million US$)
Table Global Gene Editing Market Share by Regions 2014-2019
Figure Global Gene Editing Market Share by Regions 2018-2025
Figure Global Gene Editing Market Share by Regions 2019-2025
Table Market Top Trends
Table Global Gene Editing Revenue by Manufacturers (2018-2019) (Million US$)
Table Global Gene Editing Market Share by Manufacturers (2018-2019)
Figure Global Gene Editing Market Share by Manufacturers in 2019
Table Global Key Players Gene Editing Funding/Investment Analysis (Million US$)
Table Global Key Players Gene Editing Valuation & Market Capitalization (Million US$)
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Editing Market Size by Type (2018-2025) (Million US$)
Table Global Gene Editing Market Share by Type (2018-2025)
Figure Global Gene Editing Market Size Share by Type (2018-2025)
Table Global Gene Editing Market Size by Application (2018-2025) (Million US$)
Table Global Gene Editing Market Size Share by Application (2018-2025)
Figure Global Gene Editing Market Size Market Share by Application (2018-2025)
Figure Global Gene Editing Revenue Market Share by Application in 2018
Figure United States Gene Editing Market Size 2018-2025 (Million US$)
Table United States Key Players Gene Editing Revenue (2018-2019) (Million US$)
Table United States Key Players Gene Editing Market Share (2018-2019)
Table United States Gene Editing Market Size by Type (2018-2025) (Million US$)
Table United States Gene Editing Market Share by Type (2018-2025)
Table United States Gene Editing Market Size by Application (2018-2025) (Million US$)
Table United States Gene Editing Market Share by Application (2018-2025)
Figure Europe Gene Editing Market Size 2018-2025 (Million US$)
Table Europe Key Players Gene Editing Revenue (2018-2019) (Million US$)
Table Europe Key Players Gene Editing Market Share (2018-2019)
Table Europe Gene Editing Market Size by Type (2018-2025) (Million US$)
Table Europe Gene Editing Market Share by Type (2018-2025)
Table Europe Gene Editing Market Size by Application (2018-2025) (Million US$)
Table Europe Gene Editing Market Share by Application (2018-2025)
Figure China Gene Editing Market Size 2018-2025 (Million US$)
Table China Key Players Gene Editing Revenue (2018-2019) (Million US$)
Table China Key Players Gene Editing Market Share (2018-2019)
Table China Gene Editing Market Size by Type (2018-2025) (Million US$)
Table China Gene Editing Market Share by Type (2018-2025)
Table China Gene Editing Market Size by Application (2018-2025) (Million US$)
Table China Gene Editing Market Share by Application (2018-2025)
Figure Market Size in Japan Gene Editing 2018-2025 (Million US$)
Figure Market Size in Southeast Asia Gene Editing 2018-2025 (Million US$)
Figure Market Size in India Gene Editing 2018-2025 (Million US$)
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Gene Editing Business in 2018 and 2019
Table Thermo Fisher Scientific Recent Development
Table Merck Company Details
Table Merck Revenue in Gene Editing Business in 2018 and 2019
Table Merck Recent Development
Table Horizo​​n Discovery Company Details
Table Horizo​​n Discovery Revenue in Gene Editing Business in 2018 and 2019
Table Horizo​​n Discovery Recent Development
Table Sangamo BioSciences Company Details
Table Sangamo BioSciences Revenue in Gene Editing Business in 2018 and 2019
Table Sangamo BioSciences Recent Development
Table Integrated DNA Technologies Company Details
Table Integrated DNA Technologies Revenue in Gene Editing Business in 2018 and 2019
Table Integrated DNA Technologies Recent Development
Table Lonza Company Details
Table Lonza Revenue in Gene Editing Business in 2018 and 2019
Table Lonza Recent Development
Table New England Biolabs Company Details
Table New England Biolabs Revenue in Gene Editing Business in 2018 and 2019
Table New England Biolabs Recent Development
Table OriGene Technologies Company Details
Table OriGene Technologies Revenue in Gene Editing Business in 2018 and 2019
Table OriGene Technologies Recent Development
Table Transposagen Biopharmaceuticals Company Details
Table Transposagen Biopharmaceuticals Revenue in Gene Editing Business in 2018 and 2019
Table Transposagen Biopharmaceuticals Recent Development
Table Editas Medicine Company Details
Table Editas Medicine Revenue in Gene Editing Business in 2018 and 2019
Table Editas Medicine Recent Development
Table CRISPR Therapeutics Company Details
Table RGen Solutions Company Details
Table Sigma-Aldrich Company Details
Table GeneCopoeia Company Details
Table Genscript Biotech Company Details
Table OriGene Technologies Company Details
Table Agilent Technologies Company Details
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Gemstones are elements of minerals which when polished and cut are used for making jewelry and other ornaments, as well as for decoration purposes.
Key drivers attributing to the expansion include early applications of DNA editing to therapeutics. Use of the technology for the disease eradication through direct correction of disturbances in normal physiology, engineering the immune response, and alteration of pathogen targets in the host is anticipated to drive the market with substantial opportunities.
Based on end user, the global gene editing technologies market has been segmented into biotechnology industry, horticulture industry, animal breeding and academic & research institutes. Academic and research institutes are expected to contribute maximum share in the global gene editing technologies market over the f recast period as majority of the therapeutic applications of gene editing are not yet commercialized.
United States is expected to lead the global market due to increasing number academic and research institutes. Market in APAC region is expected to witness significant growth rate over the forecast period owing to expansion activities by key market players in the region.
In 2018, the global Gene Editing market size was xx million US$ and it is expected to reach xx million US$ by the end of 2025, with a CAGR of xx% during 2019-2025.

This report focuses on the global Gene Editing status, future forecast, growth opportunity, key market and key players. The study objectives are to present the Gene Editing development in United States, Europe and China.

The key players covered in this study
Thermo Fisher Scientific
Merck
Horizo​​n Discovery
Sangamo BioSciences
Integrated DNA Technologies
Lonza
New England Biolabs
OriGene Technologies
Transposagen Biopharmaceuticals
Editas Medicine
CRISPR Therapeutics
RGen Solutions
Sigma-Aldrich
GeneCopoeia
Genscript Biotech
OriGene Technologies
Agilent Technologies

Market analysis by product type
Crispr
Talen
Zfn

Market analysis by market
Biotechnology & Pharmaceutical Companies
Academic & Government Research Institutes
Contract Research Organizations

Market analysis by Region
United States
Europe
China
Japan
Southeast Asia
India
Central & South America

The study objectives of this report are:
To analyze global Gene Editing status, future forecast, growth opportunity, key market and key players.
To present the Gene Editing development in United States, Europe and China.
To strategically profile the key players and comprehensively analyze their development plan and strategies.
To define, describe and forecast the market by product type, market and key regions.

In this study, the years considered to estimate the market size of Gene Editing are as follows:
History Year: 2018-2019
Base Year: 2018
Estimated Year: 2019
Forecast Year 2019 to 2025
For the data information by region, company, type and application, 2018 is considered as the base year. Whenever data information was unavailable for the base year, the prior year has been considered.

Read More

Table of Contents

1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type

1.4.2 Crispr
1.4.3 Talen
1.4.4 Zfn
1.5 Market by Application
1.5.1 Global Gene Editing Market Share by Application (2018-2025)
1.5.2 Biotechnology & Pharmaceutical Companies
1.5.3 Academic & Government Research Institutes
1.5.4 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Gene Editing Market Size
2.2 Gene Editing Growth Trends by Regions
2.2.1 Gene Editing Market Size by Regions (2018-2025)
2.2.2 Gene Editing Market Share by Regions (2018-2025)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Gene Editing Revenue by Manufacturers (2018-2019)
3.2 Gene Editing Key Players Head office and Area Served
3.3 Key Players Gene Editing Product/Solution/Service
3.4 Date of Enter into Gene Editing Market
3.5 Key Players Gene Editing Funding/Investment Analysis
3.6 Global Key Players Gene Editing Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Editing Market Size by Type (2018-2025)
4.2 Global Gene Editing Market Size by Application (2017-2025)

5 United States
5.1 United States Gene Editing Market Size (2018-2025)
5.2 Gene Editing Key Players in United States
5.3 United States Gene Editing Market Size by Type
5.4 United States Gene Editing Market Size by Application

6 Europe
6.1 Europe Gene Editing Market Size (2018-2025)
6.2 Gene Editing Key Players in Europe
6.3 Europe Gene Editing Market Size by Type
6.4 Europe Gene Editing Market Size by Application

7 China
7.1 China Gene Editing Market Size (2018-2025)
7.2 Gene Editing Key Players in China
7.3 China Gene Editing Market Size by Type
7.4 China Gene Editing Market Size by Application

8 Rest of World
8.1 Japan
8.1.1 Japan Gene Editing Market Analysis
8.1.2 Key Players in
8.2 Southeast Asia
8.2.1 Southeast Asia Gene Editing Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Gene Editing Market Analysis
8.3.2 Key Players in India

9 International Players Profiles
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Company Details
9.1.2 Company Description and Business Overview
9.1.3 Gene Editing Introduction
9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2018-2019)
9.1.5 Thermo Fisher Scientific Recent Development
9.2 Merck
9.2.1 Merck Company Details
9.2.2 Company Description and Business Overview
9.2.3 Gene Editing Introduction
9.2.4 Merck Revenue in Gene Editing Business (2018-2019)
9.2.5 Merck Recent Development
9.3 Horizo​​n Discovery
9.3.1 Horizo​​n Discovery Company Details
9.3.2 Company Description and Business Overview
9.3.3 Gene Editing Introduction
9.3.4 Horizo​​n Discovery Revenue in Gene Editing Business (2018-2019)
9.3.5 Horizo​​n Discovery Recent Development
9.4 Sangamo BioSciences
9.4.1 Sangamo BioSciences Company Details
9.4.2 Company Description and Business Overview
9.4.3 Gene Editing Introduction
9.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2018-2019)
9.4.5 Sangamo BioSciences Recent Development
9.5 Integrated DNA Technologies
9.5.1 Integrated DNA Technologies Company Details
9.5.2 Company Description and Business Overview
9.5.3 Gene Editing Introduction
9.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2017-2018)
9.5.5 Integrated DNA Technologies Recent Development
9.6 Lonza
9.6.1 Lonza Company Details
9.6.2 Company Description and Business Overview
9.6.3 Gene Editing Introduction
9.6.4 Lonza Revenue in Gene Editing Business (2017-2018)
9.6.5 Lonza Recent Development
9.7 New England Biolabs
9.7.1 New England Biolabs Company Details
9.7.2 Company Description and Business Overview
9.7.3 Gene Editing Introduction
9.7.4 New England Biolabs Revenue in Gene Editing Business (2018-2019)
9.7.5 New England Biolabs Recent Development
9.8 OriGene Technologies
9.8.1 OriGene Technologies Company Details
9.8.2 Company Description and Business Overview
9.8.3 Gene Editing Introduction
9.8.4 OriGene Technologies Revenue in Gene Editing Business (2018-2019)
9.8.5 OriGene Technologies Recent Development
9.9 Transposagen Biopharmaceuticals
9.9.1 Transposagen Biopharmaceuticals Company Details
9.9.2 Company Description and Business Overview
9.9.3 Gene Editing Introduction
9.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2018-2019)
9.9.5 Transposagen Biopharmaceuticals Recent Development
9.10 Editas Medicine
9.10.1 Editas Medicine Company Details
9.10.2 Company Description and Business Overview
9.10.3 Gene Editing Introduction
9.10.4 Editas Medicine Revenue in Gene Editing Business (2018-2019)
9.10.5 Editas Medicine Recent Development
9.11 CRISPR Therapeutics
9.12 RGen Solutions
9.13 Sigma-Aldrich
9.14 GeneCopoeia
9.15 Genscript Biotech
9.16 OriGene Technologies
9.17 Agilent Technologies

10 Market Dynamics
10.1 Drivers
10.2 Opportunities
10.3 Challenges
10.4 Market Ecosystem
10.5 Market Value Chain Analysis

11 Key Findings in This Report

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details


1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered
1.4 Market Analysis by Type

1.4.2 Crispr
1.4.3 Talen
1.4.4 Zfn
1.5 Market by Application
1.5.1 Global Gene Editing Market Share by Application (2018-2025)
1.5.2 Biotechnology & Pharmaceutical Companies
1.5.3 Academic & Government Research Institutes
1.5.4 Contract Research Organizations
1.6 Study Objectives
1.7 Years Considered

2 Executive Summary
2.1 Gene Editing Market Size
2.2 Gene Editing Growth Trends by Regions
2.2.1 Gene Editing Market Size by Regions (2018-2025)
2.2.2 Gene Editing Market Share by Regions (2018-2025)
2.3 Industry Trends
2.3.1 Market Top Trends
2.3.2 Market Use Cases

3 Key Players
3.1 Gene Editing Revenue by Manufacturers (2018-2019)
3.2 Gene Editing Key Players Head office and Area Served
3.3 Key Players Gene Editing Product/Solution/Service
3.4 Date of Enter into Gene Editing Market
3.5 Key Players Gene Editing Funding/Investment Analysis
3.6 Global Key Players Gene Editing Valuation & Market Capitalization
3.7 Mergers & Acquisitions, Expansion Plans

4 Breakdown Data by Type and Application
4.1 Global Gene Editing Market Size by Type (2018-2025)
4.2 Global Gene Editing Market Size by Application (2017-2025)

5 United States
5.1 United States Gene Editing Market Size (2018-2025)
5.2 Gene Editing Key Players in United States
5.3 United States Gene Editing Market Size by Type
5.4 United States Gene Editing Market Size by Application

6 Europe
6.1 Europe Gene Editing Market Size (2018-2025)
6.2 Gene Editing Key Players in Europe
6.3 Europe Gene Editing Market Size by Type
6.4 Europe Gene Editing Market Size by Application

7 China
7.1 China Gene Editing Market Size (2018-2025)
7.2 Gene Editing Key Players in China
7.3 China Gene Editing Market Size by Type
7.4 China Gene Editing Market Size by Application

8 Rest of World
8.1 Japan
8.1.1 Japan Gene Editing Market Analysis
8.1.2 Key Players in
8.2 Southeast Asia
8.2.1 Southeast Asia Gene Editing Market Analysis
8.2.2 Key Players in Southeast Asia
8.3 India
8.3.1 India Gene Editing Market Analysis
8.3.2 Key Players in India

9 International Players Profiles
9.1 Thermo Fisher Scientific
9.1.1 Thermo Fisher Scientific Company Details
9.1.2 Company Description and Business Overview
9.1.3 Gene Editing Introduction
9.1.4 Thermo Fisher Scientific Revenue in Gene Editing Business (2018-2019)
9.1.5 Thermo Fisher Scientific Recent Development
9.2 Merck
9.2.1 Merck Company Details
9.2.2 Company Description and Business Overview
9.2.3 Gene Editing Introduction
9.2.4 Merck Revenue in Gene Editing Business (2018-2019)
9.2.5 Merck Recent Development
9.3 Horizo​​n Discovery
9.3.1 Horizo​​n Discovery Company Details
9.3.2 Company Description and Business Overview
9.3.3 Gene Editing Introduction
9.3.4 Horizo​​n Discovery Revenue in Gene Editing Business (2018-2019)
9.3.5 Horizo​​n Discovery Recent Development
9.4 Sangamo BioSciences
9.4.1 Sangamo BioSciences Company Details
9.4.2 Company Description and Business Overview
9.4.3 Gene Editing Introduction
9.4.4 Sangamo BioSciences Revenue in Gene Editing Business (2018-2019)
9.4.5 Sangamo BioSciences Recent Development
9.5 Integrated DNA Technologies
9.5.1 Integrated DNA Technologies Company Details
9.5.2 Company Description and Business Overview
9.5.3 Gene Editing Introduction
9.5.4 Integrated DNA Technologies Revenue in Gene Editing Business (2017-2018)
9.5.5 Integrated DNA Technologies Recent Development
9.6 Lonza
9.6.1 Lonza Company Details
9.6.2 Company Description and Business Overview
9.6.3 Gene Editing Introduction
9.6.4 Lonza Revenue in Gene Editing Business (2017-2018)
9.6.5 Lonza Recent Development
9.7 New England Biolabs
9.7.1 New England Biolabs Company Details
9.7.2 Company Description and Business Overview
9.7.3 Gene Editing Introduction
9.7.4 New England Biolabs Revenue in Gene Editing Business (2018-2019)
9.7.5 New England Biolabs Recent Development
9.8 OriGene Technologies
9.8.1 OriGene Technologies Company Details
9.8.2 Company Description and Business Overview
9.8.3 Gene Editing Introduction
9.8.4 OriGene Technologies Revenue in Gene Editing Business (2018-2019)
9.8.5 OriGene Technologies Recent Development
9.9 Transposagen Biopharmaceuticals
9.9.1 Transposagen Biopharmaceuticals Company Details
9.9.2 Company Description and Business Overview
9.9.3 Gene Editing Introduction
9.9.4 Transposagen Biopharmaceuticals Revenue in Gene Editing Business (2018-2019)
9.9.5 Transposagen Biopharmaceuticals Recent Development
9.10 Editas Medicine
9.10.1 Editas Medicine Company Details
9.10.2 Company Description and Business Overview
9.10.3 Gene Editing Introduction
9.10.4 Editas Medicine Revenue in Gene Editing Business (2018-2019)
9.10.5 Editas Medicine Recent Development
9.11 CRISPR Therapeutics
9.12 RGen Solutions
9.13 Sigma-Aldrich
9.14 GeneCopoeia
9.15 Genscript Biotech
9.16 OriGene Technologies
9.17 Agilent Technologies

10 Market Dynamics
10.1 Drivers
10.2 Opportunities
10.3 Challenges
10.4 Market Ecosystem
10.5 Market Value Chain Analysis

11 Key Findings in This Report

12 Appendix
12.1 Research Methodology
12.1.1 Methodology/Research Approach
12.1.1.1 Research Programs/Design
12.1.1.2 Market Size Estimation
12.1.1.3 Market Breakdown and Data Triangulation
12.1.2 Data Source
12.1.2.1 Secondary Sources
12.1.2.2 Primary Sources
12.2 Disclaimer
12.3 Author Details

Read More

List of Tables and Figures

Table Gene Editing Key Market Segments
Table Key Players Gene Editing Covered
Table Global Gene Editing Market Size Growth Rate by Type 2019-2025 (Million US$)
Figure Global Gene Editing Market Size Market Share by Type 2019-2025
Figure Crispr Figures
Table Key Players of Crispr
Figure Talen Figures
Table Key Players of Talen
Figure Zfn Figures
Table Key Players of Zfn
Table Global Gene Editing Market Size Growth by Application 2019-2025 (Million US$)
Figure Biotechnology & Pharmaceutical Companies Case Studies
Figure Academic & Government Research Institutes Case Studies
Figure Contract Research Organizations Case Studies
Figure Gene Editing Report Years Considered
Table Global Gene Editing Market Size 2018-2025 (Million US$)
Figure Global Gene Editing Market Size and Growth Rate 2018-2025 (Million US$)
Table Global Gene Editing Market Size by Regions 2019-2025 (Million US$)
Table Global Gene Editing Market Size by Regions 2018-2025 (Million US$)
Table Global Gene Editing Market Share by Regions 2014-2019
Figure Global Gene Editing Market Share by Regions 2018-2025
Figure Global Gene Editing Market Share by Regions 2019-2025
Table Market Top Trends
Table Global Gene Editing Revenue by Manufacturers (2018-2019) (Million US$)
Table Global Gene Editing Market Share by Manufacturers (2018-2019)
Figure Global Gene Editing Market Share by Manufacturers in 2019
Table Global Key Players Gene Editing Funding/Investment Analysis (Million US$)
Table Global Key Players Gene Editing Valuation & Market Capitalization (Million US$)
Table Mergers & Acquisitions, Expansion Plans
Table Global Gene Editing Market Size by Type (2018-2025) (Million US$)
Table Global Gene Editing Market Share by Type (2018-2025)
Figure Global Gene Editing Market Size Share by Type (2018-2025)
Table Global Gene Editing Market Size by Application (2018-2025) (Million US$)
Table Global Gene Editing Market Size Share by Application (2018-2025)
Figure Global Gene Editing Market Size Market Share by Application (2018-2025)
Figure Global Gene Editing Revenue Market Share by Application in 2018
Figure United States Gene Editing Market Size 2018-2025 (Million US$)
Table United States Key Players Gene Editing Revenue (2018-2019) (Million US$)
Table United States Key Players Gene Editing Market Share (2018-2019)
Table United States Gene Editing Market Size by Type (2018-2025) (Million US$)
Table United States Gene Editing Market Share by Type (2018-2025)
Table United States Gene Editing Market Size by Application (2018-2025) (Million US$)
Table United States Gene Editing Market Share by Application (2018-2025)
Figure Europe Gene Editing Market Size 2018-2025 (Million US$)
Table Europe Key Players Gene Editing Revenue (2018-2019) (Million US$)
Table Europe Key Players Gene Editing Market Share (2018-2019)
Table Europe Gene Editing Market Size by Type (2018-2025) (Million US$)
Table Europe Gene Editing Market Share by Type (2018-2025)
Table Europe Gene Editing Market Size by Application (2018-2025) (Million US$)
Table Europe Gene Editing Market Share by Application (2018-2025)
Figure China Gene Editing Market Size 2018-2025 (Million US$)
Table China Key Players Gene Editing Revenue (2018-2019) (Million US$)
Table China Key Players Gene Editing Market Share (2018-2019)
Table China Gene Editing Market Size by Type (2018-2025) (Million US$)
Table China Gene Editing Market Share by Type (2018-2025)
Table China Gene Editing Market Size by Application (2018-2025) (Million US$)
Table China Gene Editing Market Share by Application (2018-2025)
Figure Market Size in Japan Gene Editing 2018-2025 (Million US$)
Figure Market Size in Southeast Asia Gene Editing 2018-2025 (Million US$)
Figure Market Size in India Gene Editing 2018-2025 (Million US$)
Table Thermo Fisher Scientific Company Details
Table Thermo Fisher Scientific Revenue in Gene Editing Business in 2018 and 2019
Table Thermo Fisher Scientific Recent Development
Table Merck Company Details
Table Merck Revenue in Gene Editing Business in 2018 and 2019
Table Merck Recent Development
Table Horizo​​n Discovery Company Details
Table Horizo​​n Discovery Revenue in Gene Editing Business in 2018 and 2019
Table Horizo​​n Discovery Recent Development
Table Sangamo BioSciences Company Details
Table Sangamo BioSciences Revenue in Gene Editing Business in 2018 and 2019
Table Sangamo BioSciences Recent Development
Table Integrated DNA Technologies Company Details
Table Integrated DNA Technologies Revenue in Gene Editing Business in 2018 and 2019
Table Integrated DNA Technologies Recent Development
Table Lonza Company Details
Table Lonza Revenue in Gene Editing Business in 2018 and 2019
Table Lonza Recent Development
Table New England Biolabs Company Details
Table New England Biolabs Revenue in Gene Editing Business in 2018 and 2019
Table New England Biolabs Recent Development
Table OriGene Technologies Company Details
Table OriGene Technologies Revenue in Gene Editing Business in 2018 and 2019
Table OriGene Technologies Recent Development
Table Transposagen Biopharmaceuticals Company Details
Table Transposagen Biopharmaceuticals Revenue in Gene Editing Business in 2018 and 2019
Table Transposagen Biopharmaceuticals Recent Development
Table Editas Medicine Company Details
Table Editas Medicine Revenue in Gene Editing Business in 2018 and 2019
Table Editas Medicine Recent Development
Table CRISPR Therapeutics Company Details
Table RGen Solutions Company Details
Table Sigma-Aldrich Company Details
Table GeneCopoeia Company Details
Table Genscript Biotech Company Details
Table OriGene Technologies Company Details
Table Agilent Technologies Company Details
Table Research Programs/Design for This Report
Figure Bottom-up and Top-down Approaches for This Report
Figure Data Triangulation
Table Key Data Information from Secondary Sources
Table Key Data Information from Primary Sources

Read More
SELECT A FORMAT
Added to Cart

Single User

Electronic (PDF)
$3900
This license allows only one user to access the PDF.

Site License

Electronic (PDF)
$5850
This license allows all the users of an enterprise residing in one location to access the PDF

Enterprise License

Electronic (PDF)
$7800
This license allows all the employees of an enterprise to access the PDF.
Add to Cart
Buy Now (10% Discount)
OUR CUSTOMER
SecuX Technology Inc

RELATED REPORTS

Global Anti Fatty Acid Synthase Antibody Market Size Status and Forecast 2021 2027
Global Anti-Fatty Acid Synthase Antibody Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-3T5659
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Protein Expression and Purification Services Market Size Status and Forecast 2021 2027
Global Protein Expression and Purification Services Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-15N5346
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Fatty Acid Synthase FASN Inhibitors Market Size Status and Forecast 2021 2027
Global Fatty Acid Synthase (FASN) Inhibitors Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-26X5219
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

Global Custom DNA Panel Market Size Status and Forecast 2021 2027
Global Custom DNA Panel Market Size, Status and Forecast 2021-2027

120 Pages
Type: Report
Code: QYRE-Auto-13N5442
Tue Jun 15 00:00:00 UTC 2021

Add to Cart

0 Items
X
No items in the cart.
$0.0